dexmedetomidine has been researched along with Ischemic Stroke in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 7 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antunes, MA; Battaglini, D; Cruz, FF; da Silva, CM; Fernandes, MV; Pelosi, P; Robba, C; Rocco, PRM; Samary, CS; Silva, PL; Sousa, GC; Takyia, C | 1 |
| Lai, S; Li, G; Liu, Q; Wu, J | 1 |
| Chen, L; Dong, S; Duan, F; Hu, M; Huang, J; Men, Y; Zhang, Y | 1 |
| Brown, CS; Faine, B; Flack, T; Gilbert, B; Howington, GT; Laub, J; Porter, B; Rech, MA; Sarangarm, P; Slocum, GW; Zepeski, A; Zimmerman, DE | 1 |
| Bao, X; Huang, L; Lyu, J; Sun, Z; Tang, L; Zhang, M; Zhao, L; Zhou, Y | 1 |
| Antunes, MA; Battaglini, D; Braga, CL; Cruz, FF; Heil, LBB; Magalhães, RF; Pelosi, P; Robba, C; Rocco, PRM; Samary, CS; Silva, PL | 1 |
| Dong, H; Jiang, J; Jiao, Y; Shao, J; Tang, D; Wang, Z; Xu, S; Yin, W; Yu, W; Zhang, Y; Zhou, W | 1 |
1 review(s) available for dexmedetomidine and Ischemic Stroke
| Article | Year |
|---|---|
The Emergency Medicine Pharmacotherapy Literature of 2021.
Topics: Antipsychotic Agents; Dexmedetomidine; Diphenhydramine; Emergency Medicine; Fibrinolytic Agents; Humans; Ischemic Stroke; Propofol; Tranexamic Acid | 2022 |
6 other study(ies) available for dexmedetomidine and Ischemic Stroke
| Article | Year |
|---|---|
Comparative effects of dexmedetomidine and propofol on brain and lung damage in experimental acute ischemic stroke.
Topics: Animals; Brain; Brain Ischemia; Dexmedetomidine; Disease Models, Animal; Endothelial Cells; Hypnotics and Sedatives; Interleukin-1beta; Interleukin-6; Ischemic Stroke; Lung; Macrophages, Alveolar; Male; Propofol; Rats; Rats, Wistar; Thiopental; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2021 |
MiR-665 Participates in the Protective Effect of Dexmedetomidine in Ischemic Stroke by ROCK2/NF-κB Axis.
Topics: Animals; Apoptosis; Brain Ischemia; Cytokines; Dexmedetomidine; Glucose; Infarction, Middle Cerebral Artery; Ischemic Stroke; Mice; MicroRNAs; NF-kappa B; Oxygen; Reperfusion Injury; rho-Associated Kinases; Up-Regulation | 2022 |
Dexmedetomidine exerts its protective effect on cerebral ischemia reperfusion injury in mice by inhibiting ferroptosis.
Topics: Animals; Brain Ischemia; Dexmedetomidine; Disease Models, Animal; Ferroptosis; Infarction, Middle Cerebral Artery; Ischemic Stroke; Male; Mice; Mice, Inbred ICR; NF-E2-Related Factor 2; Reperfusion Injury | 2022 |
Neuroprotective Effect of Dexmedetomidine on Cerebral Ischemia-Reperfusion Injury in Rats.
Topics: Animals; Brain Ischemia; Caspase 3; Cerebral Infarction; Dexmedetomidine; Glial Fibrillary Acidic Protein; Humans; Ischemic Stroke; Male; Methionyl Aminopeptidases; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2023 |
Dexmedetomidine compared to low-dose ketamine better protected not only the brain but also the lungs in acute ischemic stroke.
Topics: Animals; Brain; Dexmedetomidine; Endothelial Cells; Ischemic Stroke; Ketamine; Lung; NF-E2-Related Factor 2; Rats; Rats, Wistar; Stroke; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2023 |
Dexmedetomidine maintains blood-brain barrier integrity by inhibiting Drp1-related endothelial mitochondrial dysfunction in ischemic stroke.
Topics: Adenylate Kinase; Adrenergic alpha-2 Receptor Antagonists; Animals; Blood-Brain Barrier; Cell Line; Cytokines; Dexmedetomidine; Disease Models, Animal; Dynamins; Endothelial Cells; Glial Fibrillary Acidic Protein; Humans; Indole Alkaloids; Infarction, Middle Cerebral Artery; Ischemic Stroke; Male; Mitochondria; Mitochondrial Dynamics; Neuroprotective Agents; Phosphorylation; Rats, Sprague-Dawley; Zonula Occludens-1 Protein | 2021 |